Regional differences in cardiac effects of pituitary adenylate cyclase-activating polypeptide-27 in the isolated dog heart

Author： Hirose M.   Furukawa Y.   Lakhe M.   Chiba S.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.349, Iss.2, 1998-05, pp. : 269-276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis

By  

Current Pharmaceutical Design, Vol. 17, Iss. 3, 2011-01 ,pp. : 204-214

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of pituitary adenylate cyclase activating polypeptide27 on cyclic AMP efflux and atrial dynamics in perfused beating atria

By Cui X.   Lee S.J.   Kim S.Z.   Kim S.H.   Cho K.W.  

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 129-137

Elsevier

Access to resources Recommend Favorite

Hyperalgesia induced by pituitary adenylate cyclase-activating polypeptide in the mouse spinal cord

By Narita M.   Dun S.L.   Dun N.J.   Tseng L.F.  

European Journal of Pharmacology, Vol. 311, Iss. 2, 1996-09 ,pp. : 121-126

Elsevier

Access to resources Recommend Favorite

Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Nociception and Migraine

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 4, 2015-05 ,pp. : 540-553

Bentham Science Publishers

Access to resources Recommend Favorite

The effects of pituitary adenylate cyclase-activating polypeptide on cerebral arteries and vertebral artery blood flow in anesthetized dogs

By Seki Y.   Suzuki Y.   Baskaya M.K.   Kano T.   Saito K.   Takayasu M.   Shibuya M.   Sugita K.  

European Journal of Pharmacology, Vol. 275, Iss. 3, 1995-03 ,pp. : 259-266

Elsevier

Access to resources Recommend Favorite